No Data
No Data
IMRX Stock Up on FDA's Orphan Drug Tag for Pancreatic Cancer Drug
Voyager Therapeutics Analyst Ratings
Leerink Partners Initiates Voyager Therapeutics(VYGR.US) With Buy Rating, Announces Target Price $15
Voyager Therapeutics Initiated With an Outperform at Leerink
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn Into More Strength?
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Institutional Owners May Be Pleased With Recent Gains After 5.0% Loss Over the Past Year
No Data
No Data
climbing capybara : similar thoughts especially when yesterday i was down 15% but since company is doing great financially, decided to hold and wait.
BeeDeeVee712 OP climbing capybara : You literally described the back and forth I've been having in my head...I don't get why it hasn't moved (technically has dropped) after looking through and following up on their financials, they seem rather strong and I'm not really finding any sufficient reason to explain the lack of growth, especially over a period of months, you know?
climbing capybara : yup totally get you. feeling some opportunity loss and been thining if i should move on to a stock with more volume